Home
TLSA
TLSA News

Latest Tiziana Life Sciences Ltd. (TLSA) News on January 19, 2025

3 Penny Stocks In US With Market Caps Below $300M

Simply Wall St.

6 days ago

3 Penny Stocks In US With Market Caps Below $300M

Tiziana Announces Reduction of Side Effects Commonly Seen with Discontinuation of GLP-1 Agonists with Nasal Anti-CD3

GlobeNewswire

9 days ago

Tiziana Announces Reduction of Side Effects Commonly Seen with Discontinuation of GLP-1 Agonists with Nasal Anti-CD3

Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease

GlobeNewswire

11 days ago

Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease

Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab

GlobeNewswire

a month ago

Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab

3 US Penny Stocks With Market Caps Under $200M To Consider

Simply Wall St.

a month ago

3 US Penny Stocks With Market Caps Under $200M To Consider

Tiziana Life Sciences expands Phase 2 trial for non-active SPMS

TipRanks

a month ago

Tiziana Life Sciences expands Phase 2 trial for non-active SPMS

Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers

GlobeNewswire

a month ago

Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers

Tiziana Life Sciences Secures ALS Trial Funding

TipRanks

2 months ago

Tiziana Life Sciences Secures ALS Trial Funding

MT Newswires

2 months ago

Tiziana Life Sciences Says Grant Application Approved by ALS Association

Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association

GlobeNewswire

2 months ago

Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association

Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data

GlobeNewswire

3 months ago

Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data

Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million

GlobeNewswire

3 months ago

Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million

Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study

GlobeNewswire

3 months ago

Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study

Discover October 2024's Promising US Penny Stocks

Simply Wall St.

3 months ago

Discover October 2024's Promising US Penny Stocks

Tiziana Life Sciences Plans Share Sale with Jefferies

TipRanks

3 months ago

Tiziana Life Sciences Plans Share Sale with Jefferies

Tiziana Life Sciences Advances with Promising Drug Trials

TipRanks

3 months ago

Tiziana Life Sciences Advances with Promising Drug Trials

Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease

GlobeNewswire

4 months ago

Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease

MT Newswires

5 months ago

Tiziana Life Sciences Names Ivor Elrifi as CEO

Tiziana Life Sciences Appoints New Chief Executive Officer

GlobeNewswire

5 months ago

Tiziana Life Sciences Appoints New Chief Executive Officer

MT Newswires

5 months ago

Tiziana Life Sciences Regains Nasdaq Minimum Bid Requirement

Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule

GlobeNewswire

5 months ago

Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule

Tiziana Life Sciences Granted FDA Fast Track Designation

GlobeNewswire

6 months ago

Tiziana Life Sciences Granted FDA Fast Track Designation

MT Newswires

7 months ago

Tiziana Life Sciences Gets $3.4 Million in Funding for Neurodegenerative Disease Studies

Tiziana Receives $3.4 Million in Non-Dilutive Funding

GlobeNewswire

7 months ago

Tiziana Receives $3.4 Million in Non-Dilutive Funding

Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer’s Disease with Foralumab

GlobeNewswire

7 months ago

Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer’s Disease with Foralumab

MT Newswires

7 months ago

Tiziana Says FDA Accepts Fast Track Label Submission For Multiple Sclerosis Treatment

FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclerosis

GlobeNewswire

7 months ago

FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclerosis

IBD Stock Of The Day Meta Rolls Out New AI Tools For Businesses

Investor's Business Daily

7 months ago

IBD Stock Of The Day Meta Rolls Out New AI Tools For Businesses

Credo AI Launches the World's Largest and Most Comprehensive AI Risk and Controls Library

Business Wire

7 months ago

Credo AI Launches the World's Largest and Most Comprehensive AI Risk and Controls Library

Dow Jones Futures: Apple AI Launch, Tesla Shareholder Meeting, Fed Rate 'Dot Plot' On Tap

Investor's Business Daily

7 months ago

Dow Jones Futures: Apple AI Launch, Tesla Shareholder Meeting, Fed Rate 'Dot Plot' On Tap

EnviroGold Global Closes First Tranche of Private Placement

GlobeNewswire

7 months ago

EnviroGold Global Closes First Tranche of Private Placement

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)

GuruFocus.com

7 months ago

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)

How markets digested hot jobs print: Top takeaways

Yahoo Finance Video

7 months ago

How markets digested hot jobs print: Top takeaways

SoCalGas Volunteers to Help Sort 1.8 Million Pounds of Food to Help Labor Community Services "Stamp Out Hunger"

PR Newswire

7 months ago

SoCalGas Volunteers to Help Sort 1.8 Million Pounds of Food to Help Labor Community Services "Stamp Out Hunger"

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

GlobeNewswire

7 months ago

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

MT Newswires

7 months ago

Tiziana Life Sciences' Foralumab Demonstrates Qualitative Improvement in Multiple Sclerosis Patients After 6 Months Use

Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple Sclerosis Patients Receiving Intranasal Foralumab

GlobeNewswire

7 months ago

Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple Sclerosis Patients Receiving Intranasal Foralumab

Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intranasal Foralumab

GlobeNewswire

7 months ago

Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intranasal Foralumab

Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis Research

GlobeNewswire

8 months ago

Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis Research

Tiziana Life Sciences Files for Orphan Drug Designation for Intranasal Foralumab

GlobeNewswire

8 months ago

Tiziana Life Sciences Files for Orphan Drug Designation for Intranasal Foralumab

Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Receiving Intranasal Foralumab

GlobeNewswire

9 months ago

Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Receiving Intranasal Foralumab

MT Newswires

9 months ago

Tiziana Life Sciences Says US FDA Allows Enrollment of 20 More Patients in Foralumab MS Expanded Access Program

Tiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access Program

GlobeNewswire

9 months ago

Tiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access Program

Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients in its Expanded Access Program

GlobeNewswire

9 months ago

Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients in its Expanded Access Program

Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today®

GlobeNewswire

9 months ago

Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today®

Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology

GlobeNewswire

9 months ago

Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology

Tiziana Life Sciences Announces Platform Presentation of New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology

GlobeNewswire

9 months ago

Tiziana Life Sciences Announces Platform Presentation of New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology

Tiziana Life Sciences Announces Podium Presentation at AD/PD of Nasal Anti-CD3 in Alzheimer’s Disease

GlobeNewswire

10 months ago

Tiziana Life Sciences Announces Podium Presentation at AD/PD of Nasal Anti-CD3 in Alzheimer’s Disease

Gabelli Funds to Host Pump, Valve & Water Systems Symposium at The Yale Club, New York, NY

GlobeNewswire

a year ago

Gabelli Funds to Host Pump, Valve & Water Systems Symposium at The Yale Club, New York, NY

Allspring Closed-End Funds Declare Monthly Distributions

PR Newswire

a year ago

Allspring Closed-End Funds Declare Monthly Distributions

Strength Seen in Modiv Industrial, Inc. (MDV): Can Its 7.1% Jump Turn into More Strength?

Zacks

a year ago

Strength Seen in Modiv Industrial, Inc. (MDV): Can Its 7.1% Jump Turn into More Strength?

ESGEN Acquisition Corp. Announces Updated Transaction Terms for its Pending Business Combination with Sunergy Renewables

GlobeNewswire

a year ago

ESGEN Acquisition Corp. Announces Updated Transaction Terms for its Pending Business Combination with Sunergy Renewables

D-Wave Joins Forces with Deloitte Canada to Advance Quantum Adoption

Business Wire

a year ago

D-Wave Joins Forces with Deloitte Canada to Advance Quantum Adoption

Business Wire

a year ago

Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body

SurgePays Announces Proposed Public Offering

GlobeNewswire

a year ago

SurgePays Announces Proposed Public Offering

Velo3D to Present at the 26th Annual Needham Growth Conference

Business Wire

a year ago

Velo3D to Present at the 26th Annual Needham Growth Conference

A Look At The Intrinsic Value Of FAT Brands Inc. (NASDAQ:FAT)

Simply Wall St.

a year ago

A Look At The Intrinsic Value Of FAT Brands Inc. (NASDAQ:FAT)

TLSA: First Phase II SPMS Patient Dosed

Zacks Small Cap Research

a year ago

TLSA: First Phase II SPMS Patient Dosed

Solid Biosciences Announces $109 Million Private Placement

GlobeNewswire

a year ago

Solid Biosciences Announces $109 Million Private Placement

Business Wire

a year ago

Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results

Tiziana Life Sciences Announces Updated Clinical and PET Scan Findings for Intranasal Foralumab in Two New Multiple Sclerosis Patients

GlobeNewswire

a year ago

Tiziana Life Sciences Announces Updated Clinical and PET Scan Findings for Intranasal Foralumab in Two New Multiple Sclerosis Patients

Tiziana Life Sciences to Present at Biotech Showcase Conference in San Francisco, January 8-10, 2024

GlobeNewswire

a year ago

Tiziana Life Sciences to Present at Biotech Showcase Conference in San Francisco, January 8-10, 2024

Tiziana Life Sciences Files New Patent Application for Combination Therapy of anti-CD3 (Foralumab) with GLP-1 Receptor Agonist for Additional Reduction of Obesity - Associated Inflammation

GlobeNewswire

a year ago

Tiziana Life Sciences Files New Patent Application for Combination Therapy of anti-CD3 (Foralumab) with GLP-1 Receptor Agonist for Additional Reduction of Obesity - Associated Inflammation

Stonegate Capital Partners Updates Coverage on Pathfinder Bancorp, Inc. (PBHC) Q3 2023

Newsfile

a year ago

Stonegate Capital Partners Updates Coverage on Pathfinder Bancorp, Inc. (PBHC) Q3 2023

ACCESSWIRE

a year ago

iAccess Alpha Tax Loss Recovery Summit 2024 - Buyside Best Ideas January 9th-10th 2024

Foghorn Therapeutics Announces CFO Departure

GlobeNewswire

a year ago

Foghorn Therapeutics Announces CFO Departure

Athira Pharma Completes Enrollment of Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease

GlobeNewswire

a year ago

Athira Pharma Completes Enrollment of Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease

Riverview Bancorp Declares Quarterly Cash Dividend of $0.06 Per Share

GlobeNewswire

a year ago

Riverview Bancorp Declares Quarterly Cash Dividend of $0.06 Per Share

Alphavest Acquisition Corp Announces Adjournment of Extraordinary General Meeting of Shareholders

GlobeNewswire

a year ago

Alphavest Acquisition Corp Announces Adjournment of Extraordinary General Meeting of Shareholders

Jefferies initiates coverage on Chewy, other pet stocks

Yahoo Finance Video

a year ago

Jefferies initiates coverage on Chewy, other pet stocks

Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab in Multiple Sclerosis

GlobeNewswire

a year ago

Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab in Multiple Sclerosis

Battalion Oil Corporation Announces Acquisition By Fury Resources, Inc.

GlobeNewswire

a year ago

Battalion Oil Corporation Announces Acquisition By Fury Resources, Inc.

The 7 Best Bargain Growth Stocks to Buy Before 2024

InvestorPlace

a year ago

The 7 Best Bargain Growth Stocks to Buy Before 2024

Valens Semiconductor Appoints Guy Nathanzon as Chief Financial Officer

PR Newswire

a year ago

Valens Semiconductor Appoints Guy Nathanzon as Chief Financial Officer

RGC Resources Inc. (RGCO) Upgraded to Strong Buy: What Does It Mean for the Stock?

Zacks

a year ago

RGC Resources Inc. (RGCO) Upgraded to Strong Buy: What Does It Mean for the Stock?

NMG Identified as Industry-Leading Natural Graphite Producer in Benchmark Mineral Intelligence’s Sustainability Index

Business Wire

a year ago

NMG Identified as Industry-Leading Natural Graphite Producer in Benchmark Mineral Intelligence’s Sustainability Index

Penny Stock Jackpots: 3 High-Stakes Picks With 10-Bagger Potential

InvestorPlace

a year ago

Penny Stock Jackpots: 3 High-Stakes Picks With 10-Bagger Potential

Tiziana Life Sciences to Present at the Webull LIVE! with Corporate Connect: Biotech Investment Webinar

GlobeNewswire

a year ago

Tiziana Life Sciences to Present at the Webull LIVE! with Corporate Connect: Biotech Investment Webinar

Tiziana Life Sciences Announces Foralumab Dosing of Four New Patients in the Expanded Access Program for Multiple Sclerosis

GlobeNewswire

a year ago

Tiziana Life Sciences Announces Foralumab Dosing of Four New Patients in the Expanded Access Program for Multiple Sclerosis

Business Wire

a year ago

Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer

Great week for Intevac, Inc. (NASDAQ:IVAC) institutional investors after losing 31% over the previous year

Simply Wall St.

a year ago

Great week for Intevac, Inc. (NASDAQ:IVAC) institutional investors after losing 31% over the previous year

Arbe Wins Self-Driving Industry 2023 Award from Cars of the Future

PR Newswire

a year ago

Arbe Wins Self-Driving Industry 2023 Award from Cars of the Future

Gabelli Convertible and Income Securities Fund Declares Fourth Quarter Distribution of $0.12 per Share

GlobeNewswire

a year ago

Gabelli Convertible and Income Securities Fund Declares Fourth Quarter Distribution of $0.12 per Share

The L.S. Starrett Company Announces Fiscal 2024 First Quarter Results

Business Wire

a year ago

The L.S. Starrett Company Announces Fiscal 2024 First Quarter Results

Apyx Medical Corporation (NASDAQ:APYX) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Apyx Medical Corporation (NASDAQ:APYX) Q3 2023 Earnings Call Transcript

Relmada Therapeutics Inc (RLMD) Reports Third Quarter 2023 Financial Results

GuruFocus.com

a year ago

Relmada Therapeutics Inc (RLMD) Reports Third Quarter 2023 Financial Results

Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results

PR Newswire

a year ago

Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results

Vaxart Inc (VXRT) Reports Q3 2023 Financial Results and Business Updates

GuruFocus.com

a year ago

Vaxart Inc (VXRT) Reports Q3 2023 Financial Results and Business Updates

SelectQuote Inc (SLQT) Reports Q1 2024 Earnings: Revenue Up by 43%, Net Loss Narrows

GuruFocus.com

a year ago

SelectQuote Inc (SLQT) Reports Q1 2024 Earnings: Revenue Up by 43%, Net Loss Narrows

Via Renewables, Inc. Reports Third Quarter 2023 Financial Results

ACCESSWIRE

a year ago

Via Renewables, Inc. Reports Third Quarter 2023 Financial Results

Share on Social Networks: